Local homelessness group asks Barren County for $75,000 from opioid-settlement funds; court to convene review panel after NET Recovery demo
May 22, 2026 | Barren County, Kentucky
This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »
A representative from Bridge Kentucky asked Barren County magistrates for $75,000 from the county's opioid-settlement funds to expand services for people experiencing homelessness and to broaden the group's reach.
Bridge Kentucky's presenter said the organization has served more than 250 people since 2022 and asked for $75,000 so it can continue housing and support services, promising transparency in how any funds would be spent. The presenter listed board members in attendance and said private donations have sustained the program to date.
Judge Byrd responded that the county has placed opioid-settlement money into an interest-bearing account and will not spend it without an established process. The court agreed to form an opioid committee, to include magistrates, the jailer and sheriff, and additional government-focused appointees; the committee will solicit applications and make transparent funding recommendations before any allocation.
The court then heard a separate presentation from NET Recovery, a provider of a cranial neurostimulation device the presenter said is FDA-cleared and used to reduce withdrawal symptoms. The NET Recovery representative described clinical and programmatic use in jails and treatment facilities, cited internal long-term data they said show 86% of treated people remain abstinent at three years, and stated the per-treatment price is about $5,000 (noting the company does not sell devices, but charges per treatment and provides trained technicians).
NET Recovery offered the county two free treatments to observe results and said the device is already used in several jails and treatment centers. Magistrates and staff asked about oversight, where treatments would occur, and insurance coverage; the NET representative said eligibility screening, medical oversight and nursing support are used and that insurance adoption typically follows about four years after FDA approval.
The judge directed that the opioid committee be formed at the next general meeting to develop application criteria and transparent allocation processes before any funds are released for programs such as Bridge Kentucky or device-based pilots.
Bridge Kentucky's presenter said the organization has served more than 250 people since 2022 and asked for $75,000 so it can continue housing and support services, promising transparency in how any funds would be spent. The presenter listed board members in attendance and said private donations have sustained the program to date.
Judge Byrd responded that the county has placed opioid-settlement money into an interest-bearing account and will not spend it without an established process. The court agreed to form an opioid committee, to include magistrates, the jailer and sheriff, and additional government-focused appointees; the committee will solicit applications and make transparent funding recommendations before any allocation.
The court then heard a separate presentation from NET Recovery, a provider of a cranial neurostimulation device the presenter said is FDA-cleared and used to reduce withdrawal symptoms. The NET Recovery representative described clinical and programmatic use in jails and treatment facilities, cited internal long-term data they said show 86% of treated people remain abstinent at three years, and stated the per-treatment price is about $5,000 (noting the company does not sell devices, but charges per treatment and provides trained technicians).
NET Recovery offered the county two free treatments to observe results and said the device is already used in several jails and treatment centers. Magistrates and staff asked about oversight, where treatments would occur, and insurance coverage; the NET representative said eligibility screening, medical oversight and nursing support are used and that insurance adoption typically follows about four years after FDA approval.
The judge directed that the opioid committee be formed at the next general meeting to develop application criteria and transparent allocation processes before any funds are released for programs such as Bridge Kentucky or device-based pilots.
View the Full Meeting & All Its Details
This article offers just a summary. Unlock complete video, transcripts, and insights as a Founder Member.
✓
Watch full, unedited meeting videos
✓
Search every word spoken in unlimited transcripts
✓
AI summaries & real-time alerts (all government levels)
✓
Permanent access to expanding government content
30-day money-back guarantee
